Tempus AI's growth is fueled by data services and acquisitions, despite financial risks. Key Q2 results may shape its path to ...

Tempus AI offers a strong business model with AI-driven genomic data, resilient demand, and significant growth prospects.

Deep 6’s platform strengthens Tempus AI’s provider connectivity, now totaling over 4,000 connections, and facilitates the two-way exchange of clinical and molecular data.

Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC ...

Tempus AI (NASDAQ: TEM), a healthcare technology company, posted impressive Q1 results with revenue reaching $255.7 million, up 75.4% year-over-year. Adjusted EBITDA improved significantly to $-16 ...

Over the past year, shares of Tempus AI and Butterfly Network have surged 55.4% and 114.8%, respectively, handily outperforming the broader Medical Info Systems industry’s 13.6% gain and the S&P ...

Tempus AI is a growth stock that is down 31% from all-time highs. Here's why TEM AI stock could be a part of your TFSA portfolio right now.

NEW ORLEANS, July 16, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 12, 2025 to file lead plaintiff applications in a ...

The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC) jumped 0.4% and 0.6%, respectively. Tempus, a ...

June 02, 2025 — 05:22 pm EDT Written by Johnny Rice for The Motley Fool -> Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close.